Safety and Feasibility of Intravenous Autologous Bone Marrow Derived Stem Cell Therapy for Patients with Acute Ischaemic Stroke: An Open-Label, Phase I Trial

被引：0
|
作者：
Prasad, Kameshwar
Bhatia, Rohit
Mohanty, Sujata
Srivastava, M. V. Padma
Garg, Ajay
Srivastava, Achal
Goyal, Vinay
Tripathi, Manjari
Kumar, Amit
Vij, Arti
Misra, N. K.
Bal, C. S.
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A509 / A510
页数：2
相关论文
共 50 条
  • [31] Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial
    Granel, Brigitte
    Daumas, Aurelie
    Jouve, Elisabeth
    Harle, Jean-Robert
    Nguyen, Pierre-Sebastien
    Chabannon, Christian
    Colavolpe, Nathalie
    Reynier, Jean-Charles
    Truillet, Romain
    Mallet, Stephanie
    Baiada, Antoine
    Casanova, Dominique
    Giraudo, Laurent
    Arnaud, Laurent
    Veran, Julie
    Sabatier, Florence
    Magalon, Guy
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (12) : 2175 - 2182
  • [32] Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa
    Rashidghamat, Ellie
    Kadiyirire, Tendai
    Ayis, Salma
    Petrof, Gabriela
    Liu, Lu
    Pullabhatla, Venu
    Ainali, Chrysanthi
    Guy, Alyson
    Aristodemou, Sophia
    McMillan, James R.
    Ozoemena, Linda
    Mee, John
    Pramanik, Rashida
    Saxena, Alka
    Nuamah, Rosamund
    de Rinaldis, Emanuele
    Serrano, Sonia
    Maurin, Clarisse
    Martinez-Queipo, Magdalena
    Lwin, Su M.
    Ilic, Dusko
    Martinez, Anna
    Dazzi, Francesco
    Slaper-Cortenbach, Ineke
    Westinga, Kasper
    Zeddies, Sabrina
    van den Broek, Marcel
    Onoufriadis, Alexandros
    Mellerio, Jemima E.
    McGrath, John A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (02) : 447 - 454
  • [33] Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients
    Taguchi, Akihiko
    Sakai, Chiaki
    Soma, Toshihiro
    Kasahara, Yukiko
    Stern, David M.
    Kajimoto, Katsufumi
    Ihara, Masafumi
    Daimon, Takashi
    Yamahara, Kenichi
    Doi, Kaori
    Kohara, Nobuo
    Nishimura, Hiroyuki
    Matsuyama, Tomohiro
    Naritomi, Hiroaki
    Sakai, Nobuyuki
    Nagatsuka, Kazuyuki
    STEM CELLS AND DEVELOPMENT, 2015, 24 (19) : 2207 - 2218
  • [34] Autologous bone marrow mononuclear cell infusion and hyperbaric oxygen therapy in type 2 diabetes mellitus: an open-label, randomized controlled clinical trial
    Wu, Zhixian
    Cai, Jinquan
    Chen, Jin
    Huang, Lianghu
    Wu, Weizhen
    Luo, Fang
    Wu, Chenguang
    Liao, Lianming
    Tan, Jianming
    CYTOTHERAPY, 2014, 16 (02) : 258 - 265
  • [35] Feasibility and safety of autologous cord blood derived cell administration in extremely preterm infants: a single-centre, open-label, single-arm, phase I trial (CORD-SaFe study)
    Zhou, Lindsay
    Mcdonald, Courtney A.
    Yawno, Tamara
    Razak, Abdul
    Connelly, Kristyn
    Novak, Iona
    Miller, Suzanne L.
    Jenkin, Graham
    Malhotra, Atul
    EBIOMEDICINE, 2025, 111
  • [36] Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial
    Davalos, Antoni
    Cobo, Erik
    Molina, Carlos A.
    Chamorro, Angel
    Angeles de Miquel, M.
    San Roman, Luis
    Serena, Joaquin
    Lopez-Cancio, Elena
    Ribo, Marc
    Millan, Monica
    Urra, Xabier
    Cardona, Pere
    Tomasello, Alejandro
    Castano, Carlos
    Blasco, Jordi
    Aja, Lucia
    Rubiera, Marta
    Gomis, Meritxell
    Renu, Arturo
    Lara, Blanca
    Marti-Fabregas, Joan
    Jankowitz, Brian
    Cerda, Neus
    Jovin, Tudor G.
    LANCET NEUROLOGY, 2017, 16 (05): : 369 - 376
  • [37] Stem cell therapy in diabetic men with erectile dysfunction: a 24-month follow-up of safety and efficacy of two intracavernous autologous bone marrow derived mesenchymal stem cells injections, an open label phase 2 clinical trial
    Al Demour, Saddam
    Adwan, Sofia
    Jafar, Hanan
    Alhawari, Hussam
    Awidi, Abdalla
    BASIC AND CLINICAL ANDROLOGY, 2024, 34 (01)
  • [38] Safety of efalizumab therapy in patients with moderate to severe psoriasis - An open-label extension of a phase IIIb trial
    Hamilton, Tiffani
    Menter, Alan
    Caro, Ivor
    Compton, Peter
    Sobell, Jeffrey
    Papp, Kim A.
    DRUG SAFETY, 2008, 31 (08) : 715 - 726
  • [39] Safety of Efalizumab Therapy in Patients with Moderate to Severe PsoriasisAn Open-Label Extension of a Phase IIIb Trial
    Tiffani Hamilton
    Alan Menter
    Ivor Caro
    Peter Compton
    Jeffrey Sobell
    Kim A. Papp
    Drug Safety, 2008, 31 : 715 - 726
  • [40] Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: An open-label, dose-ranging, phase I study
    Qureshi, Adnan I.
    Harris-Lane, Pansy
    Kirmani, Jawad F.
    Janjua, Nazli
    Divani, Afshin A.
    Mohammad, Yousef M.
    Suarez, Jose I.
    Montgomery, Michael O.
    NEUROSURGERY, 2006, 59 (04) : 789 - 796
12345